SEATTLE, WA, July 22, 2022 -- McapMediaWire -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical assets from Wuhan General Group (China), Inc in an all-cash-transaction ("Purchase''). "This purchase is a perfect match to our business model and supports both our strategy in this sector and our direction to continue to create a path for success for our shareholders," said Kim Halvorson,...
Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets
read more
